Hollister Biosciences Inc. Announces $5 Million Private Placement
January 20, 2021 17:36 ET | Source: Hollister Biosciences Inc. Hollister Biosciences Inc. THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
VANCOUVER, British Columbia, Jan. 20, 2021 (GLOBE NEWSWIRE) Hollister Biosciences Inc. (CSE:HOLL, OTC:HSTRF, FRANKFURT:HOB) (“
Hollister” or the “
Company”) is pleased to announce that it has entered into a letter of engagement with Eight Capital, pursuant to which Eight Capital, acting as sole bookrunner and lead agent, has agreed to offer for sale, together with a syndicate of agents (together with Eight Capital, the “
iFabric Withdraws Public Offering of Units and Launches Private Placement of Subscription Receipts
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
Pasofino Gold Announces Annual General and Special Meeting, Approval of Consolidation of Common Shares and Election of New Director
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Pasofino Gold Limited: Pasofino Gold Announces Annual General and Special Meeting, Approval of Consolidation of Common Shares and Election of New Director
Pasofino or the
Company ) is pleased to announce that at its annual general and special meeting held on December 21, 2020 (the
Meeting ), shareholders of the Company approved all matters brought before them, including: (i) the fixing of the number of Directors of the Company at five (5) and the election of Robert Metcalfe to the board of directors; (ii) the appointment of McGovern Hurley LLP, Chartered Accountants, as auditors of the Company; (iii) the reapproval of the Company s stock option plan; and (iv) the consolidation of the issued and outstanding common shares in the capital of the Company (the